## Abstract Although the incidence of testis cancer has risen markedly in many Western populations over the past halfβcentury, it is not clear whether rates in other populations also have increased. To clarify this issue, we examined testis cancer incidence rates over the 25βyear time period of 197
International trends and patterns of primary liver cancer
β Scribed by Katherine A. McGlynn; Lilian Tsao; Ann W. Hsing; Susan S. Devesa; Joseph F. Fraumeni Jr.
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 156 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0020-7136
- DOI
- 10.1002/ijc.1456
No coin nor oath required. For personal study only.
β¦ Synopsis
Primary liver cancer (PLC) is common in many areas of the developing world, but uncommon in most of the developed world. Some evidence suggests, however, that the global pattern of PLC may be changing. To clarify this issue, we examined incidence rates for PLC over the 15-year time period, 1978 -92, in selected cancer registries around the world. With some exceptions, developed countries have experienced PLC increases in incidence whereas developing countries have experienced declines. Although the reasons for the trends are not entirely clear, the increased seroprevalence of HCV in the developed world and the elimination of HBV-cofactors in the developing world are likely to have contributed to the patterns. Further progress against PLC may be seen in the developing world once the HBV-vaccinated segment of the population reaches adulthood.
π SIMILAR VOLUMES
dying from primary cancer of the liver, as well as those with this disease diagnosed in Nashville hospitals, over a 17-year period along with their age-, sex-, and race-matched controls have had interview data collected to identify background factors. The reported excess of cancer of several types a
the in situ freezing of tumor, i.e., cryotherapy, was performed with liquid nitrogen (-196Β°C) on 235 patients with primary liver cancer (PLC). There were no operative mortalities or severe complications. The 5-year survival was 39.8% for the 235 PLC patients, and 55.4% for the 80 patients with small